ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,086.49
0.61%
US Tech 100
20,900.00
1.09%
다우존스 지수
45,014.04
0.69%
Bitcoin
98,620.63
-0.14%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 유럽
  5. EU

  6. Celyad Oncology SA (CYAD) 시세

Celyad Oncology SA

Celyad Oncology SA (CYAD)

EU
0.789
0.027
(3.54%)
마감 05 12월 1:30AM
15분 지연

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

프리미엄

주요 통계 및 세부정보

가격
0.789
매수가
0.781
매도가
0.795
거래량
24,454
0.761 일간 변동폭 0.799
0.212 52주 범위 1.22
market_cap
32.687M
전일 종가
0.762
개장가
0.762
최근 거래 시간
260
@
0.789
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
84,855
발행 주식
41,429,000
배당수익률
-
주가수익률
-3.87
주당순이익(EPS)
-0.2
매출
102k
순이익
-8.45M

Celyad Oncology SA 정보

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.celyad.com
본부
Mont-saint-guibert, Walloon Brabant, Bel
설립됨
-
Celyad Oncology SA is listed in the Pharmaceutical Preparations sector of the 유로넥스트 (Euronext) with ticker CYAD. The last closing price for Celyad Oncology was 0.76 €. Over the last year, Celyad Oncology shares have traded in a share price range of 0.212 € to 1.22 €.

Celyad Oncology currently has 41,429,000 shares in issue. The market capitalisation of Celyad Oncology is 31.57 € million. Celyad Oncology has a price to earnings ratio (PE ratio) of -3.87.

CYAD 최신 뉴스

추가 뉴스

Celyad Oncology Présentera au Congrès Annuel SITC 2024

Regulatory News: Celyad Oncology (Euronext: CYAD) (la “Société”), annonce aujourd'hui la présentation de deux posters lors de la 39e réunion annuelle de la Society for Immunotherapy of Cancer...

08 10월 2024
Business Wire

Celyad Oncology announces intention to terminate SEC reporting obligations

MONT-SAINT-GUIBERT, Belgium, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) announces that it will voluntarily file a Form 15F with...

09 2월 2024
GlobeNewswire Inc.

Celyad Oncology provides fourth quarter 2023 business update and 2024 outlook

Three main pillars to unlock the potential of proprietary technology platforms and intellectual property: A proprietary non-gene editing technology platform based on multiplexing of short hairpin...

17 1월 2024
GlobeNewswire Inc.

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announces, in accordance with Article 14 of the...

21 12월 2023
GlobeNewswire Inc.

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces that 6,500,000 shares of CFIP CLYD (UK...

16 12월 2023
GlobeNewswire Inc.

Celyad announces management change

MONT-SAINT-GUIBERT, Belgium, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD), a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of...

05 12월 2023
GlobeNewswire Inc.

Publication of a transparency notification received from Tolefi SA (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Dec. 01, 2023 (GLOBE NEWSWIRE) -- regulated information – Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance...

01 12월 2023
GlobeNewswire Inc.

Publication of a transparency notification received from Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance with Article 14 of the...

22 11월 2023
GlobeNewswire Inc.

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

MONT-SAINT-GUIBERT, Belgium, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext: CYAD) (the “Company” or “Celyad Oncology”), today announces the below information following the...

15 11월 2023
GlobeNewswire Inc.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.10415.18248175180.6850.850.637930310.74344295DE
40.4215114.6938775510.36751.220.34952097130.79765789DE
120.564250.6666666670.2251.220.225848550.69159607DE
260.494167.4576271190.2951.220.212464490.61676938DE
520.409107.6315789470.381.220.212369470.52854776DE
156-3.701-82.42761692654.494.60.212391761.24438813DE
260-10.351-92.917414721711.1412.080.212423803.69126439DE

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ALCOXNicox SA
0.2895 €
(32.49%)
1.34M
ALGTRGroupe Tera SA
2.40 €
(28.34%)
410
ALSAFSAFE
0.086 €
(23.92%)
80.01k
ALAGOEPango SA
0.1062 €
(16.45%)
2.54M
MLCMIScemi
3.96 €
(14.45%)
4
ALCYBCybergun
0.0001 €
(-50.00%)
2.68M
ALTMENoxxon Pharma NV
0.0896 €
(-42.34%)
4.69M
GNROGeNeuro SA
0.0428 €
(-34.56%)
1.05k
ALEUPEuroplasma
0.047 €
(-32.86%)
2.61M
ATOAtos SE
0.339 €
(-31.52%)
14.65M
ALNEVNeovacs
0.0003 €
(0.00%)
52.59M
BCPBanco Comercial Portugues SA
0.4469 €
(0.27%)
34.35M
ATOAtos SE
0.339 €
(-31.52%)
14.65M
ORAOrange.
9.414 €
(-3.01%)
14.62M
ALHPIHopium SA
0.0089 €
(3.49%)
11.09M

토론

전체 피드 보기
WebSlinger WebSlinger 4 분 전
The Scumbag CEO also states that they have about $1.5 million in cash, which is another lie.

The latest financial (from end of Sep) shows that they had $1.2 million and that was over 2 months ago.
KBLB
tat4tat tat4tat 4 분 전
Tomorrow makes Q three weeks late. Clown act trying to fill big shoes.
CEOS
Golden Cross Golden Cross 4 분 전
$ILLR Opportunity to Leverage ILLR’s Underutilized Assets to Create Next-Gen Entertainment Platform
https://www.youtube.com/watch?v=2XxZ-TKOLng
ILLR
doc2016 doc2016 5 분 전
photonic data storage comms to the charge photon qubit? do the charged photons have a memristor state?
IONQ
Golden Cross Golden Cross 5 분 전
$ILLR Opportunity to Leverage ILLR’s Underutilized Assets to Create Next-Gen Entertainment Platform
https://www.youtube.com/watch?v=2XxZ-TKOLng
ILLR
Tahoe2468 Tahoe2468 5 분 전
style="caret-color: rgb(210, 210, 210); color: rgba(210, 210, 210, 1); font-family: -apple-system-font; font-size: 18px; background-color: rgba(0, 0, 0, 1)"Danny Meeks, the Chief Executive Officer of Greenwave Technology Solutions, Inc. (NASDAQ:GWAV), recently purchased a significant amount of the c
GWAV
devil dog 96 devil dog 96 5 분 전
You and the rest of the promoter clowns🤡 have been pushing this no proof scam theory clown🤡 show promo propaganda for years now as her micro unrestricted share count (float) stays micro. 😃 LMAO https://www.otcmarkets.com/stock/ATMH/security

" Is that because it
ATMH
doc2016 doc2016 5 분 전
kona, but msft, lg, samsung, hp, interwoven have perpetual 744 family licenses........they never extinguish, or so it would seem.
mascale mascale 6 분 전
Jack+Herer poster appears to have no UK bar association credential to post--the similar matter for the alleged geological credential--better said a data cherry-picking "credential," likely Fictionary based. That is shown in other posts. Matters of sovereignty are best said those.
HIRU
ANTI-BAGHOLDER ANTI-BAGHOLDER 6 분 전
Nice!  Good stuff! He'll yeah he is.
MONI
CDG3 CDG3 6 분 전
$AUNXF - Company webinar update was very good and the growth potential is stellar w/a significant disconnect of their stock price. This company is primed and the stock will catch up.
AUNXF
Kick Up Kick Up 6 분 전
Lakota, couldn’t agree more! Looking backwards is a fools errand. Nothing back there will help on the road ahead!
WDLF
patrik patrik 6 분 전
Good to see you still around golferman,
Take care,
Patrik
KBLB
iamthe walrus iamthe walrus 6 분 전
Why don't you join us here on the CRTG journey. Things have just recently begun changing for Coretec . No guarantees but less risk than there's was
CRTG
jtomm jtomm 7 분 전
SSLCF - From listening to some interviews that mgt has done, the inventory is not so much a directional bet on pricing, but rather, preparing to meet demand that they believe is already there. This latest acquisition used to have much higher revenues and went from like $20m down to $12m. Mgt contact
djmcga djmcga 7 분 전
4:1 stock split today 
ANET
Nightdaytrader Nightdaytrader 8 분 전
Francois Gagnon advises various stakeholders with regards to restructurings , etc...

https://www.blg.com/en/people/g/gagnon-fran%C3%A7ois
ERHE
JohnnyHydrogen JohnnyHydrogen 8 분 전
AI data centers

https://youtu.be/GdUOaWrHGUA?si=1onKXYOq3Ffm5BRJ

This video shows the governor / premiere of Alberta Canada. She is specifically talking about AI data centers using natural gas. There is no doubt that this is going to be a humongous opportunity. The vide
FCEL
boston127 boston127 9 분 전
It seems to me that increasing the

company's value by $3M, in a short span of time, by selling shares indicates that there is interest in the company. This happened with the pps not being affected. This is a frustrating investment, not one of my good ones. I should have thrown everyt
LGHL
crazy horse 0 crazy horse 0 9 분 전
TY I like this update very positive IMO

Quote
I also believe that having Form 10 data lodged with the SEC and publicly available will likely be helpful as RITE navigates through the targeted acquisitions in our pipeline.

$RITE MineralRite Corporation (RITE) Re
RITE
CrimsonNightRider CrimsonNightRider 9 분 전
SOON

https://investorshub.advfn.com/uimage/uploads/2023/10/21/dumiaIMG_4770.gif
IQST
holt69 holt69 9 분 전
If you talk to Glickman you'll find out they have no plans to address the share price in the imminent future. He claims Fernandez and co aren't happy with the share price, but they're not going to do anything different about it. Which really tells you they have no issue with the share price. A reve
NXPL
Nightdaytrader Nightdaytrader 10 분 전
François Gagnon , a partner in BLG's Financial Services Group, is also a member of the Insolvency and Financial Restructuring Group. He frequently represents secured and unsecured creditors, monitors, trustees, insolvent debtor companies, directors and asset purchasers in restructurings under the
ERHE

최근 히스토리

EU
CYAD
Celyad Oncology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유